Bristol Myers Squibb (CELG-RI) Goodwill (2009 - 2026)
Bristol Myers Squibb (CELG-RI) posted quarterly Goodwill of $21.7 billion for Q1 2026, little changed YoY from $21.7 billion in Q1 2025, and little changed sequentially from $21.8 billion in Q4 2025.
Bristol Myers Squibb (CELG-RI) Goodwill (2009 - 2026) Analysis & Trends
Bristol Myers Squibb has disclosed Goodwill across 18 years of filings, most recently posting $21.7 billion for Q1 2026.
- In Q1 2026, Goodwill changed 0.01% year-over-year to $21.7 billion; the TTM figure through Mar 2026 stood at $21.7 billion (changed 0.01% YoY), while the FY2025 annual figure was $21.8 billion, changed 0.16% from the prior year.
- Goodwill held at $21.7 billion in Q1 2026, from $21.8 billion in the prior quarter.
- Over the last five years, Goodwill for CELG-RI reached as high as $21.8 billion in Q2 2025 and fell as low as $20.4 billion in Q2 2022.
- The 5-year median for Goodwill is $21.7 billion (2024), against an average of $21.4 billion.
- Annual changes were most pronounced in 2022 — Goodwill dropped 0.4% — and 2023, when it increased 3.51%.
- A 5-year view of Goodwill shows it stood at $21.1 billion in 2022, then increased by 0.09% to $21.2 billion in 2023, then grew by 2.6% to $21.7 billion in 2024, then climbed by 0.16% to $21.8 billion in 2025, then fell by 0.06% to $21.7 billion in 2026.
- According to Business Quant data, Goodwill over the past three periods registered $21.7 billion, $21.8 billion, and $21.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Bristol Myers Squibb | 244.56 Mn | -10.21 Bn | 8.07 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.74 Bn |
| Dec 31, 2025 | 21.75 Bn |
| Sep 30, 2025 | 21.75 Bn |
| Jun 30, 2025 | 21.78 Bn |
| Mar 31, 2025 | 21.74 Bn |
| Dec 31, 2024 | 21.72 Bn |
| Sep 30, 2024 | 21.75 Bn |
| Jun 30, 2024 | 21.73 Bn |
| Mar 31, 2024 | 21.74 Bn |
| Dec 31, 2023 | 21.17 Bn |
| Sep 30, 2023 | 21.15 Bn |
| Jun 30, 2023 | 21.16 Bn |
| Mar 31, 2023 | 21.16 Bn |
| Dec 31, 2022 | 21.15 Bn |
| Sep 30, 2022 | 21.11 Bn |
| Jun 30, 2022 | 20.45 Bn |
| Mar 31, 2022 | 20.50 Bn |
| Dec 31, 2021 | 20.50 Bn |
| Sep 30, 2021 | 20.52 Bn |
| Jun 30, 2021 | 20.53 Bn |